October 22, 2024

Exclusive Markets Receives Top Honors at International Business Magazine Awards 2024

Exclusive Markets Receives Top Honors at International Business Magazine Awards 2024 DUBAI, United Arab Emirates, Oct. 22, 2024 (GLOBE NEWSWIRE) — Exclusive Markets, a globally renowned leader in online multi-asset trading, has once again showcased its commitment to excellence by holding several prestigious awards at the highly esteemed International Business Magazine Awards 2024. The company […]

Exclusive Markets Honoured with “Top Trusted Financial Institution in the Financial Markets” Award in 2024

Exclusive Markets Honoured with “Top Trusted Financial Institution in the Financial Markets” Award in 2024 DUBAI, United Arab Emirates, Oct. 22, 2024 (GLOBE NEWSWIRE) — Exclusive Markets, a globally celebrated online multi-asset trading platform, has been awarded the prestigious title of Top Trusted Financial Institution in the Financial Markets, by Top 100 Trusted Financial Institutions at the Middle East […]

Exclusive Markets Honoured with “Top Trusted Financial Institution in the Financial Markets” Award in 2024

Exclusive Markets Honoured with “Top Trusted Financial Institution in the Financial Markets” Award in 2024 DUBAI, United Arab Emirates, Oct. 22, 2024 (GLOBE NEWSWIRE) — Exclusive Markets, a globally celebrated online multi-asset trading platform, has been awarded the prestigious title of Top Trusted Financial Institution in the Financial Markets, by Top 100 Trusted Financial Institutions at the Middle East […]

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin’s innate glucosyltransferase in order to inhibit the toxin produced by C. diff. in the gastrointestinal tract. There are up to 175,000 cases of recurrent C. diff. each […]

Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions

Quantexa earned a top ranking in the RiskTech100® 2025 Report, highlighting its strength and innovation in the expanding risk technology and compliance market LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) — Quantexa, a leading provider of Decision Intelligence solutions for public and private sectors, today announced it has received recognition in two Chartis Research reports. Quantexa […]